FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1600959780> ?p ?o ?g. }

• W1600959780 abstract "Eczema is an inflammatory skin disease that tends to involve skin creases, such as the folds of the elbows or knees; it is an intensely itchy skin condition, which can relapse and remit over time. As many as a third of people with eczema who have a positive test for allergy to house dust mite have reported worsening of eczema or respiratory symptoms when exposed to dust.To assess the effects of all house dust mite reduction and avoidance measures for the treatment of eczema.We searched the following databases up to 14 August 2014: the Cochrane Skin Group Specialised Register, CENTRAL in The Cochrane Library (2014, Issue 8), MEDLINE (from 1946), Embase (from 1974), LILACS (from 1982), and the GREAT database. We also searched five trials registers and checked the reference lists of included and excluded studies for further references to relevant studies. We handsearched abstracts from international eczema and allergy meetings.Randomised controlled trials (RCTs) of any of the house dust mite reduction and avoidance measures for the treatment of eczema, which included participants of any age diagnosed by a clinician with eczema as defined by the World Allergy Organization. We included all non-pharmacological and pharmacological interventions that sought to reduce or avoid exposure to house dust mite and their allergenic faeces. The comparators were any active treatment, no treatment, placebo, or standard care only.Two authors independently checked the titles and abstracts identified, and there were no disagreements. We contacted authors of included studies for additional information. We assessed the risk of bias using Cochrane methodology.We included seven studies of 324 adults and children with eczema. Overall, the included studies had a high risk of bias. Four of the seven trials tested interventions with multiple components, and three tested a single intervention. Two of the seven trials included only children, four included children and adults, and one included only adults. Interventions to reduce or avoid exposure to house dust mite included covers for mattresses and bedding, increased or high-quality vacuuming of carpets and mattresses, and sprays that kill house dust mites.Four studies assessed our first primary outcome of 'Clinician-assessed eczema severity using a named scale'. Of these, one study (n = 20) did not show any significant short-term benefit from allergen impermeable polyurethane mattress encasings and acaricide spray versus allergen permeable cotton mattress encasings and placebo acaricide spray. One study (n = 60) found a modest statistically significant benefit in the Six Area, Six Sign Atopic Dermatitis (SASSAD) scale over six months (mean difference of 4.2 (95% confidence interval 1.7 to 6.7), P = 0.008) in favour of a mite impermeable bedding system combined with benzyltannate spray and high-filtration vacuuming versus mite permeable cotton encasings, water with a trace of alcohol spray, and a low-filtration vacuum cleaner. The third study (n = 41) did not compare the change in severity of eczema between the two treatment groups. The fourth study (n = 86) reported no evidence of a difference between the treatment groups.With regard to the secondary outcomes 'Participant- or caregiver-assessed global eczema severity score' and the 'Amount and frequency of topical treatment required', one study (n = 20) assessed these outcomes with similar results being reported for these outcomes in both groups. Four studies (n = 159) assessed 'Sensitivity to house dust mite allergen using a marker'; there was no clear evidence of a difference in sensitivity levels reported between treatments in any of the four trials.None of the seven included studies assessed our second primary outcome 'Participant- or caregiver-assessed eczema-related quality of life using a named instrument' or the secondary outcome of 'Adverse effects'.We were unable to combine any of our results because of variability in the interventions and paucity of data.We were unable to determine clear implications to inform clinical practice from the very low-quality evidence currently available. The modest treatment responses reported were in people with atopic eczema, specifically with sensitivity to one or more aeroallergens. Thus, their use in the eczema population as a whole is unknown. High-quality long-term trials of single, easy-to-administer house dust mite reduction or avoidance measures are worth pursuing." @default.
• W1600959780 created "2016-06-24" @default.
• W1600959780 creator A5015127442 @default.
• W1600959780 creator A5020273160 @default.
• W1600959780 creator A5022274311 @default.
• W1600959780 creator A5030536801 @default.
• W1600959780 creator A5062933348 @default.
• W1600959780 creator A5067192498 @default.
• W1600959780 creator A5088390482 @default.
• W1600959780 date "2015-01-19" @default.
• W1600959780 modified "2023-10-16" @default.
• W1600959780 title "House dust mite reduction and avoidance measures for treating eczema" @default.
• W1600959780 cites W1511865831 @default.
• W1600959780 cites W1520172273 @default.
• W1600959780 cites W1527957830 @default.
• W1600959780 cites W161335602 @default.
• W1600959780 cites W1747966476 @default.
• W1600959780 cites W1852007369 @default.
• W1600959780 cites W1879089629 @default.
• W1600959780 cites W1964591531 @default.
• W1600959780 cites W1967010539 @default.
• W1600959780 cites W1969261465 @default.
• W1600959780 cites W1973857582 @default.
• W1600959780 cites W1974246538 @default.
• W1600959780 cites W1976665465 @default.
• W1600959780 cites W1976694836 @default.
• W1600959780 cites W1982906465 @default.
• W1600959780 cites W1986665363 @default.
• W1600959780 cites W1988415448 @default.
• W1600959780 cites W1988990442 @default.
• W1600959780 cites W1990520453 @default.
• W1600959780 cites W1992153121 @default.
• W1600959780 cites W1992245040 @default.
• W1600959780 cites W1993584864 @default.
• W1600959780 cites W1993705126 @default.
• W1600959780 cites W1997345000 @default.
• W1600959780 cites W1998850091 @default.
• W1600959780 cites W2016391707 @default.
• W1600959780 cites W2017351855 @default.
• W1600959780 cites W2019414101 @default.
• W1600959780 cites W2029916679 @default.
• W1600959780 cites W2036870870 @default.
• W1600959780 cites W2037682462 @default.
• W1600959780 cites W2039525081 @default.
• W1600959780 cites W2049379137 @default.
• W1600959780 cites W2059264376 @default.
• W1600959780 cites W2061705388 @default.
• W1600959780 cites W2061765860 @default.
• W1600959780 cites W2063525031 @default.
• W1600959780 cites W2071937455 @default.
• W1600959780 cites W2072241656 @default.
• W1600959780 cites W2085716005 @default.
• W1600959780 cites W2087343666 @default.
• W1600959780 cites W2097901958 @default.
• W1600959780 cites W2099249590 @default.
• W1600959780 cites W2101460636 @default.
• W1600959780 cites W2105040298 @default.
• W1600959780 cites W2121652459 @default.
• W1600959780 cites W2126595246 @default.
• W1600959780 cites W2134045853 @default.
• W1600959780 cites W2134317330 @default.
• W1600959780 cites W2136339403 @default.
• W1600959780 cites W2140654551 @default.
• W1600959780 cites W2143138262 @default.
• W1600959780 cites W2144661996 @default.
• W1600959780 cites W2146802812 @default.
• W1600959780 cites W2149036814 @default.
• W1600959780 cites W2150894711 @default.
• W1600959780 cites W2152214488 @default.
• W1600959780 cites W2162557362 @default.
• W1600959780 cites W2165415673 @default.
• W1600959780 cites W2230668301 @default.
• W1600959780 cites W2290199870 @default.
• W1600959780 cites W2403882668 @default.
• W1600959780 cites W4237840131 @default.
• W1600959780 cites W4319293042 @default.
• W1600959780 doi "https://doi.org/10.1002/14651858.cd008426.pub2" @default.
• W1600959780 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8407038" @default.
• W1600959780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25598014" @default.
• W1600959780 hasPublicationYear "2015" @default.
• W1600959780 type Work @default.
• W1600959780 sameAs 1600959780 @default.
• W1600959780 citedByCount "25" @default.
• W1600959780 countsByYear W16009597802015 @default.
• W1600959780 countsByYear W16009597802016 @default.
• W1600959780 countsByYear W16009597802017 @default.
• W1600959780 countsByYear W16009597802018 @default.
• W1600959780 countsByYear W16009597802019 @default.
• W1600959780 countsByYear W16009597802020 @default.
• W1600959780 countsByYear W16009597802021 @default.
• W1600959780 countsByYear W16009597802022 @default.
• W1600959780 countsByYear W16009597802023 @default.
• W1600959780 crossrefType "journal-article" @default.
• W1600959780 hasAuthorship W1600959780A5015127442 @default.
• W1600959780 hasAuthorship W1600959780A5020273160 @default.
• W1600959780 hasAuthorship W1600959780A5022274311 @default.
• W1600959780 hasAuthorship W1600959780A5030536801 @default.
• W1600959780 hasAuthorship W1600959780A5062933348 @default.
• W1600959780 hasAuthorship W1600959780A5067192498 @default.
• W1600959780 hasAuthorship W1600959780A5088390482 @default.

• next